FDA approves 1st drug for aggressive multiple sclerosis

TRENTON, N.J. - U.S. regulators have approved the first drug for an aggressive kind of multiple sclerosis that steadily reduces co-ordination and the ability to walk.The Food and Drug Administration approved Ocrevus late Tuesday after a large study found it slowed progression of the